Published on
June 10, 2025
- 12:15 GMT
OrisDX Raises $4M Seed to Launch First-of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer
Pioneering saliva-based multiomic platform from Chicago secures $4M Seed from leading East and West coast investors to transform early oral cancer detection CHICAGO, IL, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- OrisDX, a precision diagnostics …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
